Neuroimaging Studies of the Treatment of Bipolar Depression With Citalopram
NCT01639482 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2019-03-07
Summary
Regional metabolic changes associated with response to 6 weeks of citalopram treatment, using 18-Fluorodeoxyglucose Positron Emission Tomography imaging, will be characterized (FDG PET).
Conditions
Sponsors & Collaborators
-
Massachusetts General Hospital
lead OTHER
Principal Investigators
-
Darin D Dougherty, MD · Massachusetts General Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 64 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-04-30
- Primary Completion
- 2013-12-31
- Completion
- 2013-12-31
Countries
- United States
Study Locations
More Related Trials
-
Functional and Neurochemical Brain Changes Bipolar Depression
NCT00608296 ·Status: COMPLETED
-
Neurofunctional and Neurochemical Markers of Treatment Response in Bipolar Disorder
NCT00608075 ·Status: UNKNOWN ·Phase: PHASE4
-
Neurophysiologic Changes in Patients With Bipolar Depression
NCT01213121 ·Status: UNKNOWN ·Phase: PHASE4
-
FMRI Study of Brain Response Before and After Lithium Treatment in People With Bipolar Disorder
NCT00596622 ·Status: COMPLETED ·Phase: PHASE4
-
Functional Connectivity in Mood Regulating Circuit In Bipolar Depression and Mania
NCT00457054 ·Status: COMPLETED ·Phase: PHASE4
-
Brain Derived Neurotrophic Factor as a Predictor of Response to Treatment in Bipolar Depression and Mania
NCT00879632 ·Status: UNKNOWN
-
Differentiating Unipolar and Bipolar Depression in Young Adults Using fMRI
NCT01811147 ·Status: COMPLETED ·Phase: PHASE4
-
A Glutamate Transporter GLT1, in the Treatment of Bipolar Disorder
NCT00512616 ·Status: WITHDRAWN ·Phase: PHASE2
-
Circadian Phase in Bipolar Depression: Is it Delayed and Does it Normalize With Remission?
NCT01784341 ·Status: COMPLETED
-
Neurofeedback for Bipolar Disorder
NCT05802446 ·Status: RECRUITING ·Phase: NA
-
Functional and Neurochemical Brain Changes in First-episode Bipolar Mania
NCT00609193 ·Status: COMPLETED
-
Olanzapine/Fluoxetine Combination Versus Comparator in the Treatment of Bipolar I Depression
NCT00485771 ·Status: COMPLETED ·Phase: PHASE4
-
Magnetic Resonance Imaging Study of Lisdexamfetamine for Bipolar Depression
NCT01051440 ·Status: TERMINATED ·Phase: PHASE4
-
The Evaluation and Follow-up of Patients With Bipolar Disorder
NCT00001652 ·Status: COMPLETED
-
Neural and Visual Responses to Light in Bipolar Disorder: A Novel Putative Biomarker
NCT02048995 ·Status: COMPLETED
-
Lithium Effects on the Brain's Functional and Structural Connectome in the Treatment of Bipolar Disorder
NCT03336918 ·Status: ACTIVE_NOT_RECRUITING
-
A Close Examination of Patient Experiences in Bipolar Disorder Clinical Trials
NCT05891639 ·Status: NOT_YET_RECRUITING
-
Bipolar Depression Before and After Lamotrigine Treatment
NCT01042496 ·Status: COMPLETED ·Phase: PHASE3
-
Depakote ER in Bipolar Depression
NCT00186186 ·Status: COMPLETED ·Phase: PHASE4
-
Brain Derived Neurotrophic Factor as a Predictor of Response to Treatment in Bipolar Depression and Mania: 16-weeks Follow-up With Quetiapine XR
NCT00879307 ·Status: UNKNOWN ·Phase: PHASE3
-
MAPP: Imagery-focused Therapy for Bipolar Disorder
NCT01981018 ·Status: COMPLETED ·Phase: NA
-
Natural History of Depression, Bipolar Disorder and Suicide Risk
NCT06462196 ·Status: RECRUITING
-
Antidepressant Treatments and Cognitive Function of Bipolar Patients
NCT04564573 ·Status: UNKNOWN
-
Understanding Treatment Adherence Among Individuals With Bipolar Disorder
NCT00183495 ·Status: COMPLETED
-
Ceftriaxone in the Management of Bipolar Depression
NCT00566111 ·Status: TERMINATED ·Phase: NA